Loading...
Loading...
CDXC| Name | Value |
|---|---|
| Revenues | 21.0M |
| Cost of Revenue | 9.0M |
| Gross Profit | 12.0M |
| Operating Expense | 13.5M |
| Operating I/L | -1.4M |
| Other Income/Expense | 0.0M |
| Interest Income | 0.0M |
| Pretax | -1.4M |
| Income Tax Expense | -2.1M |
| Net Income/Loss | 0.7M |
ChromaDex Corporation is a bioscience company specializing in healthy aging. It operates through three segments: Consumer products, Ingredients, and Analytical Reference Standards and Services. The company researches nicotinamide adenine dinucleotide (NAD+) and provides finished dietary supplement products containing proprietary ingredients to consumers and distributors. It also develops and commercializes ingredient technologies, such as NIAGEN, a flagship NAD+ precursor, and IMMULINA for immune support. Additionally, ChromaDex offers analytical reference standards and services for quality control in various industries. The company generates revenue by selling its proprietary ingredients and consumer products directly to consumers, distributors, specialty retailers, and healthcare practitioners.
